TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target. Alzforum, 10 Jun 2022 Li RY, Qin Q, Yang HC, Wang YY, Mi YX, Yin YS, Wang M, Yu CJ, Tang Y. Mol Neurodegener.